- \n
- Vad Yazvinski Skeptical Capitalist<\/a><\/strong><\/li>\n
- Jim Van Meerten – Strategy Lab<\/a><\/strong><\/li>\n
- Ken Kam – Marketocracy<\/a><\/strong><\/li>\n
- Howard Gold The Money Show<\/a><\/strong><\/li>\n
- John Reese Validea.com<\/a><\/strong><\/li>\n<\/ul>\n
LISTEN TO PODCAST<\/span><\/a> | LISTEN @ ZUNE<\/a> – @ iTUNES<\/a><\/span><\/span><\/strong><\/p>\n
During this Money Show show, the big interest seemed to be in Biotech. \u00a0 Not surprisingly, that was one of the subtitles of the conference. But, it was interesting how passionate the bio-techies are about the promise of a miracle drug find for the companies they are following and investing in. It appears to me that that is a game of chance with higher odds and lower success rates than traditional investing methods.<\/p>\n
Jon Markman<\/a><\/strong> was on hand to provide his cadre of followers some great insight into spin-offs, IPOs and reverse splits. I sat in on his lecture entitled, \u201cFrom worst to first.\u201d\u009d He explained how these specialty stock plays actually perform and when is the best time to invest.<\/p>\n
** Charts discussed (click for chart) – Adobe<\/strong><\/a> (ADBE) and Central European Distributing<\/strong><\/a> (CEDC) **<\/p>\n
—<\/p>\n
Stocks Discusse<\/strong>d<\/strong>: Adobe (ADBE) \u00a0Central \u00a0European Distribution (CEDC) ProShares (SMS) Mosaic (MOS) Potash (POT) Interpid Potash (IPI) Sanderson Farms (SAFM) ITT Education (ESI) Proshares Oil (DUG)<\/p>\n
<\/a><\/p>\n
![\"Play\"](\"https:\/\/thedisciplinedinvestor.com\/blog\/wp-content\/uploads\/powerpress\/TDI_PlayPodcast-679.png\" "\\"Play\\"")
<\/a><\/div>\nPodcast: Play in new window<\/a> | Download<\/a> (18.0MB)<\/p>
Subscribe: Spotify<\/a> | TuneIn<\/a> | RSS<\/a> | More<\/a><\/p>","protected":false},"excerpt":{"rendered":"
Coming to you from The Money Show in San Francisco. Listen in to the Strategy Lab panel highlights, Jon Markman of MSN Money and Andrew sits down with Vad Yazvinski the winner of Strategy Lab 17.<\/p>\n
<\/a><\/div>\nPodcast: Play in new window<\/a> | Download<\/a> (18.0MB)<\/p>
Subscribe: Spotify<\/a> | TuneIn<\/a> | RSS<\/a> | More<\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[9,251],"tags":[71,482,499,490,244],"class_list":["post-855","post","type-post","status-publish","format-standard","hentry","category-podcasts","category-msn-strategy-lab","tag-oil","tag-podcasts","tag-shownotes","tag-stocks","tag-strategy-lab","et-doesnt-have-format-content","et_post_format-et-post-format-standard"],"acf":[],"_links":{"self":[{"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/posts\/855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/comments?post=855"}],"version-history":[{"count":0,"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/posts\/855\/revisions"}],"wp:attachment":[{"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/media?parent=855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/categories?post=855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thedisciplinedinvestor.com\/blog\/wp-json\/wp\/v2\/tags?post=855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Jim Van Meerten – Strategy Lab<\/a><\/strong><\/li>\n